A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/18413836

Clin. Cancer Res. 2008 Apr 15 14 8 2444-9

Download in:

View as

Triples

General Info

PMID
18413836